Hemodialysis access thrombosis

Keith Bertram Quencer, Rahmi Oklu

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

For the over 400,000 patients in the United States dependent on hemodialysis, arteriovenous (AV) access thrombosis may lead to missed dialysis sessions, inpatient admissions and the need for placement of temporary dialysis catheters. It is also the leading cause of permanent access loss. Percutaneous declotting is generally preferred over surgical thrombectomy. Various percutaneous approaches can be employed including the lyse-and-wait technique, thromboaspiration, pulse spray aided pharmacomechanical thrombolysis, and use of mechanical thrombectomy device.

Original languageEnglish (US)
Pages (from-to)S299-S308
JournalCardiovascular Diagnosis and Therapy
Volume7
DOIs
StatePublished - Dec 1 2017

    Fingerprint

Keywords

  • Arteriovenous fistula (AVF)
  • Arteriovenous graft (AVG)
  • AV access thrombosis
  • Pulse spray aided pharmacomechanical thrombolysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this